Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07246161

Vaginal Detection of Orally Delivered Probiotic Strains in Healthy Women

Detection of Orally Delivered Probiotic Strains in the Vaginal Microbiome of Healthy Female Adults

Status
Recruiting
Phase
Phase 2
Study type
Interventional
Enrollment
72 (estimated)
Sponsor
Lallemand Health Solutions · Industry
Sex
Female
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

The purpose of the present study is to obtain more information on the transit of orally ingested probiotics to the vagina.

Detailed description

Probiotics have emerged as novel supplements to support women's health, demonstrating benefits in maintain vaginal health and promoting recovery from dysbiosis. This includes various oral and vaginal probiotics shown to alleviate symptoms and enhance the reversal of vaginal dysbiosis. Oral delivered probiotic strains suggest their ability to migrate and colonize the vagina to support vaginal health but is not well understood. Therefore, this study will aim to provide additional information on their transit to the vagina.

Conditions

Interventions

TypeNameDescription
OTHERProbiotic Formula 1Includes 2 different probiotic strains differing from other intervention groups.
OTHERProbiotic Formula 2Includes 2 different probiotic strains differing from other intervention groups.
OTHERProbiotic Formula 3Includes 2 different probiotic strains differing from other intervention groups.

Timeline

Start date
2025-10-20
Primary completion
2026-06-01
Completion
2026-06-01
First posted
2025-11-24
Last updated
2025-11-26

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT07246161. Inclusion in this directory is not an endorsement.